clinical trial · NCT03461146
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Anemia; Hemodialysis Dependent Chronic Kidney DiseaseMT-6548
brief summary
For hemodialysis subjects not receiving ESAs with anemia associated with chronic kidney disease, evaluate Hb correction and maintenance effect and safety of MT-6548.
started
Mar 5, 2018
primary completion
Dec 3, 2018
completion
Dec 17, 2018
last updated
Apr 6, 2026
official title
A Phase III, Open-label Study of MT-6548 in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol